← Leaderboards
Stephen Raymond Thom
University Of Pennsylvania
$6,841,868
Attributed
$9,312,962
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $767.3K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,227,945 · 8
By mechanism
R01$8,879,837 · 4
P50$7,914,983 · 3
R21$433,125 · 1
Top collaborators
- David J. Margolis9 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- David J. Margolis$22,280,628
- David H Jang$4,927,970
- Sunday O Akintoye$3,651,037
- Ara A Chalian$0
- Abu-Bakr Al-Mehdi$0
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsHyperbaric Oxygen TherapyAnimalsBiochemicalAlternative MedicineOxidative StressNitric Oxide SynthaseAcuteResponseWound HealingNeuropathyCharacteristicsWoundDiabetes MellitusHealingDiabeticStemStem CellsNitric OxideEventBlood SpecimenCell PhysiologyFoot UlcerLaboratory Rat
Grant awards (33)
Inflammatory changes and glymphatic dysfunction in carbon monoxide neuropathology$586,646
R01 · FY2025 · NS · contact PI
Inflammatory changes and glymphatic dysfunction in carbon monoxide neuropathology$569,046
R01 · FY2024 · NS · contact PI
Inflammatory changes and glymphatic dysfunction in carbon monoxide neuropathology$586,646
R01 · FY2023 · NS · contact PI
Inflammatory changes and glymphatic dysfunction in carbon monoxide neuropathology$614,728
R01 · FY2022 · NS · contact PI
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers$513,501
R01 · FY2021 · DK
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers$605,066
R01 · FY2020 · DK
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers$546,142
R01 · FY2019 · DK
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers$586,818
R01 · FY2018 · DK
Stem cell mobilization and diabetic skin ulcers$147,122
R01 · FY2016 · DK · contact PI
Stem cell mobilization and diabetic skin ulcers$596,346
R01 · FY2015 · DK · contact PI
Stem cell mobilization and diabetic skin ulcers$594,179
R01 · FY2014 · DK · contact PI
Stem cell mobilization and diabetic skin ulcers$585,706
R01 · FY2013 · DK · contact PI
Stem cell mobilization and diabetic skin ulcers$767,308
R01 · FY2012 · DK · contact PI
Stem Cell Mobilization in Diabetes$236,250
R21 · FY2009 · DK · contact PI
Stem Cell Mobilization in Diabetes$196,875
R21 · FY2008 · DK · contact PI
SPECIALIZED CENTER OF RESEARCH IN HYPERBARIC OXYGEN THER$1,669,793
P50 · FY2004 · AT
SPECIALIZED CENTER OF RESEARCH IN HYPERBARIC OXYGEN THER$1,622,289
P50 · FY2003 · AT
CO POISONING IN THE CONTEXT OF A REPERFUSION INJURY$396,250
R01 · FY2003 · ES
SPECIALIZED CENTER OF RESEARCH IN HYPERBARIC OXYGEN THER$1,587,774
P50 · FY2002 · AT
CO POISONING IN THE CONTEXT OF A REPERFUSION INJURY$396,250
R01 · FY2002 · ES
Core--Hyperbaric chamber$0
P50 · FY2002 · AT
Oxygen evaluation of nitric oxide production in vivo$0
P50 · FY2002 · AT
SPECIALIZED CENTER OF RESEARCH IN HYPERBARIC OXYGEN THER$1,533,532
P50 · FY2001 · AT
CO POISONING IN THE CONTEXT OF A REPERFUSION INJURY$396,250
R01 · FY2001 · ES
SPECIALIZED CENTER OF RESEARCH IN HYPERBARIC OXYGEN THER$3,172
P50 · FY2001 · AT
Core--Hyperbaric chamber$0
P50 · FY2001 · AT
Core--Hyperbaric chamber$0
P50 · FY2001 · AT
Oxygen evaluation of nitric oxide production in vivo$0
P50 · FY2001 · AT
Oxygen evaluation of nitric oxide production in vivo$0
P50 · FY2001 · AT
SPECIALIZED CENTER OF RESEARCH IN HYPERBARIC OXYGEN THER$1,498,423
P50 · FY2000 · AT
CO POISONING IN THE CONTEXT OF A REPERFUSION INJURY$391,833
R01 · FY2000 · ES
Core--Hyperbaric chamber$0
P50 · FY2000 · AT
Oxygen evaluation of nitric oxide production in vivo$0
P50 · FY2000 · AT